30 results on '"Rüfer, Axel"'
Search Results
2. Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial
3. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
4. Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries
5. Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET
6. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012
7. Mast cell leukemia:clinical and molecular features and survival outcomes of patients in the ECNM Registry
8. Immunomodulation with romiplostim as a second‐line strategy in primary immune thrombocytopenia: The iROM study.
9. Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP.
10. CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma
11. Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)
12. Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium
13. Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)
14. Management of transthyretin amyloidosis
15. Identification of a JAK2 FERM Domain Variant Associated With Hereditary Thrombocytosis
16. Management of transthyretin amyloidosis
17. Unusual manifestation of an endocrine-active testicular tumor
18. Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis
19. Hereditary hyperferritinemia-cataract syndrome (HHCS) presenting with iron deficiency anemia associated with a new mutation in the iron responsive element of the L ferritin gene in a swiss family
20. Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor–refractory multiple myeloma
21. Diagnostik und Therapie myelodysplastischer Syndrome
22. Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2-Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14
23. Hyperéosinophilie
24. Maladie de Vaquez
25. Polycythaemia vera
26. Die Milz bei nicht-malignen hämatologischen Erkrankungen
27. Multicenter Phase II Trial of Bendamustine, Lenalidomide and Dexamethasone (BRd) As 2nd-Line Therapy for Multiple Myeloma
28. Reference values for oral iron absorption of bivalent iron in healthy volunteers.
29. [The spleen in non-malignant haematological disorders].
30. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.